Coronado Biosciences Announces Sale of Common Stock in Its At-the-Market Public Offering
April 11, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., April 11, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Host Analyst Event in New York City
April 03, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., April 3, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
March 14, 2013 07:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., March 14, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Present at the ROTH 25th Annual Growth Stock Conference
March 11, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., March 11, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Report Fourth Quarter and Full Year 2012 Results
March 07, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., March 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Present at the Cowen and Co. 33rd Annual Health Care Conference
February 27, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences Announces Initiation of Investigator-Initiated Study Evaluating TSO in Psoriasis
February 25, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences Signs Research Collaboration and License Agreement With Freie Universitat Berlin for Secretory Products of Trichuris suis
February 22, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 22, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Participate in Panel Discussion at the Citi 2013 Global Healthcare Conference
February 19, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 19, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Present at the Leerink Swann 2013 Global Healthcare Conference
February 07, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...